Is this the beginning of the end for HIV?

From FS Magazine, Matthew Hodson writes on the importance of getting PrEP to those who need it.

The end of year reviews of 2016 were pretty damning. Bowie, Prince and George Michael led a long list of musical heroes who left us. Brexit in the UK and Trump in the US upset the pollsters and divided both nations. Worldwide, there was a succession of murderous atrocities committed, not least a bloody attack on a gay nightclub in Miami. And Princess Leia died. And then her mum died too.

But just before Christmas there was one bit of good news. 56 Dean Street, the busiest sexual health clinic in Europe, announced that they had seen a 40% drop in new HIV diagnoses. Shortly afterwards other London clinics chimed in, reporting drops in new diagnoses among gay and bisexual men in 2016 of between 35% and 50%.

I found this hard to process. To hear the news I’d been hoping, fighting and campaigning for half of my adult life felt almost too good to be true.

The change couldn’t be explained away by a drop in testing, which remained roughly the same. Also, there was no significant change in the rate of other STIs, which suggested that there hadn’t been a sudden, dramatic increase in condom use or other changes in sexual behaviour.

Treatment as prevention (TasP) undoubtedly was a contributing factor. Over the last few years there has been progress in reducing the number of people living with undiagnosed infection. People with HIV now access treatment earlier and when we are undetectable on treatment we’re no longer a transmission risk. That change has been growing steadily over the last few years so it didn’t seem to explain the massive, game-changing drops that the clinics were reporting. This had to be the result of something new.

We haven’t got all the data in yet so we have to proceed with some caution but most signs suggest that it was PrEP that made the difference.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below